ANDREW SANDER: Open Payments
NPI 1417271438 · LULING, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 34 payments from 12 companies in 2025. Trend: 2023 $72 · 2024 $240 · 2025 $809
Food & beverage: $692Education: $117
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $165 |
| Axsome Therapeutics, Inc. | 6 | $142 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
| Lundbeck LLC | 3 | $80 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Supernus Pharmaceuticals, Inc. | 1 | $36 |
| Alkermes, Inc. | 1 | $27 |
Products named: REXULTI, Auvelity, Jornay PM, SPRAVATO, VRAYLAR, CAPLYTA, TRINTELLIX, Qelbree.
Industry payments across LA — which companies pay providers there.
